HALO logo
halo search icon
aTyr Pharma, Inc.

US$0.53

Price Change Indicator
0.048 (9.86%)
aTyr Pharma, Inc.
ATYR · NAS

aTyr Pharma, Inc.

Start Trading ATYR for Free

US$0.53

Price Arrow0.048 (9.86%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusBig CandleHALO AllHALO Consensus Value
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

aTyr Pharma, Inc. Overview

ATYR Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Neutral

Growth

Earnings

Neutral

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About ATYR

icon
icon

Telephone

1.858.731.8389

icon

Address

Suite 300, 10240 Sorrento Valley Road, San Diego, CA 92121

Description

aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel biological pathways. Its product pipeline includes ATYR1923, ATYR2810, NRP2 mAbs, and AARS-1, DARS-1. The company was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA.

ATYR Price Chart

Key Stats

Market Cap

US$47.36M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.4 - 7.29

Trade Value (12mth)

US$2,650,877.00

1 week

-4.17%

1 month

-41.35%

YTD

-36.37%

1 year

-87.12%

All time high

396.06

Key Fundamentals

EPS 3 yr Growth

-50.00%

EBITDA Margin

NaN%

Operating Cashflow

-$62m

Free Cash Flow Return

-77.40%

ROIC

-92.60%

Interest Coverage

0.00

Quick Ratio

5.30

Other Data

Shares Outstanding (Fully Diluted)

98m

HALO Sector

Healthcare

Next Company Report Date

18-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

ATYR Announcements

Latest Announcements

DateAnnouncements
16 May 26
16 May 26
15 May 26
12 May 26
12 May 26

ATYR Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-0.94-0.86-0.8locklocklock
EPS (Fully Diluted)
 $locklocklocklock-0.94-0.86-0.8locklocklock
Growth
 %locklocklocklock41.18.37.5locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of aTyr Pharma, Inc. (ATYR:NAS)?
Halo FAQ
The current share price of aTyr Pharma, Inc. (ATYR:NAS) is USD$0.53.
What is the 52-week high share price for aTyr Pharma, Inc. (ATYR:NAS)?
Halo FAQ
The 52-week high share price for aTyr Pharma, Inc. (ATYR:NAS) is USD$7.29.
What is the 52-week low share price for aTyr Pharma, Inc. (ATYR:NAS)?
Halo FAQ
The 52-week low share price for aTyr Pharma, Inc. (ATYR:NAS) is USD$0.40.
What is the dividend yield for aTyr Pharma, Inc. (ATYR:NAS)?
Halo FAQ
aTyr Pharma, Inc. (ATYR:NAS) does not pay a dividend.
What was aTyr Pharma, Inc. (ATYR:NAS) last dividend payment?
Halo FAQ
aTyr Pharma, Inc. (ATYR:NAS) does not pay a dividend.
What is the franking level for aTyr Pharma, Inc. (ATYR:NAS)?
Halo FAQ
aTyr Pharma, Inc. (ATYR:NAS) has a franking level of 0.00%.
In which sector is aTyr Pharma, Inc. (ATYR:NAS) classified?
Halo FAQ
aTyr Pharma, Inc. (ATYR:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial